Carregant...

Validation of a blood protein signature for non-small cell lung cancer

BACKGROUND: CT screening for lung cancer is effective in reducing mortality, but there are areas of concern, including a positive predictive value of 4% and development of interval cancers. A blood test that could manage these limitations would be useful, but development of such tests has been impai...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mehan, Michael R, Williams, Stephen A, Siegfried, Jill M, Bigbee, William L, Weissfeld, Joel L, Wilson, David O, Pass, Harvey I, Rom, William N, Muley, Thomas, Meister, Michael, Franklin, Wilbur, Miller, York E, Brody, Edward N, Ostroff, Rachel M
Format: Artigo
Idioma:Inglês
Publicat: Springer 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4123246/
https://ncbi.nlm.nih.gov/pubmed/25114662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1559-0275-11-32
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!